Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $5.06 and traded as low as $3.68. Predictive Oncology shares last traded at $3.74, with a volume of 24,195 shares trading hands.
Predictive Oncology Stock Performance
The firm has a market capitalization of $15.88 million, a price-to-earnings ratio of -0.80 and a beta of 1.54. The stock’s fifty day moving average is $5.03 and its two-hundred day moving average is $5.03.
Predictive Oncology (NASDAQ:POAI – Get Free Report) last announced its earnings results on Thursday, August 10th. The medical instruments supplier reported ($0.95) earnings per share for the quarter. Predictive Oncology had a negative net margin of 1,246.52% and a negative return on equity of 90.72%. The business had revenue of $0.49 million for the quarter.
Institutional Trading of Predictive Oncology
Predictive Oncology Company Profile
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
- Five stocks we like better than Predictive Oncology
- How to Calculate Return on Investment (ROI)
- MarketBeat Week in Review – 9/4 – 9/8
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- The Best 5 Small Cap AI Companies to Buy Now
- How to Effectively Use the MarketBeat Ratings Screener
- Miso Robotics Stock: Is an IPO Coming Soon?
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.